Zanamivir for the Treatment of Clinically Diagnosed Influenza in Clinical Practice
- 1 November 2000
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 20 (5) , 327-336
- https://doi.org/10.2165/00044011-200020050-00004
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trialThe Pediatric Infectious Disease Journal, 2000
- Zanamivir, a New Targeted Therapy in the Treatment of InfluenzaClinical Drug Investigation, 2000
- Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European StudyJournal of Infection, 2000
- Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy StudiesAntimicrobial Agents and Chemotherapy, 2000
- Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysisJournal of Antimicrobial Chemotherapy, 1999
- Chemotherapeutic control of influenzaJournal of Antimicrobial Chemotherapy, 1999
- Underused options for preventing and treating influenza.Cleveland Clinic Journal of Medicine, 1999
- Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infectionsThe Lancet, 1998
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997